ESMO 2025 – Dr. Ma’s Key Takeaways in Breast Cancer

Dr. Kim Ma shares her main takeaways from ESMO 2025, reflecting on three days of impactful breast cancer data—from adjuvant CDK4/6 trials monarchE and NATALEE, to metastatic insights from TROPION-Breast02, ASCENT-03, and the promising evERA Breast Cancer trial shaping future care.